Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 631

1.

Vedolizumab for Inflammatory Bowel Disease: two year results of the ICC Registry, a nationwide prospective observational cohort study.

Biemans VBC, van der Woude J, Dijkstra G, van der Meulen-de Jong AE, Oldenburg B, de Boer NKH, Löwenberg M, Srivastava N, Bodelier AGL, West R, Jansen JM, de Vries AC, Haans JJL, de Jong DJ, Pierik MJ, Hoentjen F; Dutch Initiative on Crohn, Colitis (ICC).

Clin Pharmacol Ther. 2019 Nov 2. doi: 10.1002/cpt.1712. [Epub ahead of print]

PMID:
31677154
2.

Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.

Rosenwald A, Bens S, Advani R, Barrans S, Copie-Bergman C, Elsensohn MH, Natkunam Y, Calaminici M, Sander B, Baia M, Smith A, Painter D, Pham L, Zhao S, Ziepert M, Jordanova ES, Molina TJ, Kersten MJ, Kimby E, Klapper W, Raemaekers J, Schmitz N, Jardin F, Stevens WBC, Hoster E, Hagenbeek A, Gribben JG, Siebert R, Gascoyne RD, Scott DW, Gaulard P, Salles G, Burton C, de Jong D, Sehn LH, Maucort-Boulch D.

J Clin Oncol. 2019 Sep 9:JCO1900743. doi: 10.1200/JCO.19.00743. [Epub ahead of print]

PMID:
31498031
3.

High frequency of inactivating tetraspanin C D37 mutations in diffuse large B-cell lymphoma at immune-privileged sites.

Elfrink S, de Winde CM, van den Brand M, Berendsen M, Roemer MGM, Arnold F, Janssen L, van der Schaaf A, Jansen E, Groenen PJTA, Eijkelenboom A, Stevens W, Hess CJ, van Krieken JH, Vermaat JSP, Cleven AHG, de Groen RAL, Neviani V, de Jong D, van Deventer S, Scheijen B, van Spriel AB.

Blood. 2019 Sep 19;134(12):946-950. doi: 10.1182/blood.2019001185. Epub 2019 Jul 31.

PMID:
31366619
4.

Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment.

Kreijne JE, de Veer RC, de Boer NK, Dijkstra G, West R, Moorsel SAW, de Jong DJ, van der Woude CJ, de Vries AC; of the Dutch Initiative on Crohn, Colitis (ICC).

Aliment Pharmacol Ther. 2019 Aug;50(4):407-415. doi: 10.1111/apt.15402.

PMID:
31359480
5.

Recent trend reversal for declining European seagrass meadows.

de Los Santos CB, Krause-Jensen D, Alcoverro T, Marbà N, Duarte CM, van Katwijk MM, Pérez M, Romero J, Sánchez-Lizaso JL, Roca G, Jankowska E, Pérez-Lloréns JL, Fournier J, Montefalcone M, Pergent G, Ruiz JM, Cabaço S, Cook K, Wilkes RJ, Moy FE, Trayter GM, Arañó XS, de Jong DJ, Fernández-Torquemada Y, Auby I, Vergara JJ, Santos R.

Nat Commun. 2019 Jul 26;10(1):3356. doi: 10.1038/s41467-019-11340-4.

6.

Rituximab-PECC induction followed by 90 Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study.

Lugtenburg PJ, Zijlstra JM, Doorduijn JK, Böhmer LH, Hoogendoorn M, Berenschot HW, Beeker A, van der Burg-de Graauw NC, Schouten HC, Bilgin YM, Kersten MJ, Koene HR, Herbers AHE, de Jong D, Hijmering N, Lam KH, Chiţu D, Brouwer RE, van Imhoff GW; Dutch HOVON group.

Br J Haematol. 2019 Nov;187(3):347-355. doi: 10.1111/bjh.16087. Epub 2019 Jul 10.

PMID:
31290569
7.

Breast Implant Prevalence in the Dutch Female Population Assessed by Chest Radiographs.

de Boer M, van Middelkoop M, Hauptmann M, van der Bijl N, Bosmans JAW, Hendriks-Brouwer N, Schop SJ, de Boer JP, Hijmering NJ, Overbeek LIH, Lobbes MBI, Klazen CAH, de Jong D, Rakhorst HA, van der Hulst RRWJ, van Leeuwen FE.

Aesthet Surg J. 2019 Jun 26. pii: sjz136. doi: 10.1093/asj/sjz136. [Epub ahead of print]

PMID:
31242279
8.

Effects of High-Level Acylsugar-Producing Tomato Lines on the Development of Tomato Psyllids (Hemiptera: Triozidae).

Li Z, Kund G, De Jong DM, Feng X, Mutschler MA, Trumble JT.

J Econ Entomol. 2019 Aug 3;112(4):1926-1931. doi: 10.1093/jee/toz070.

PMID:
31220296
9.

Ustekinumab for Crohn's disease: results of the ICC Registry, a nationwide prospective observational cohort study.

Biemans VBC, van der Meulen-de Jong AE, van der Woude CJ, Löwenberg M, Dijkstra G, Oldenburg B, de Boer NKH, van der Marel S, Bodelier AGL, Jansen JM, Haans JJL, Theeuwen R, de Jong D, Pierik MJ, Hoentjen F; Dutch Initiative on Crohn and Colitis (ICC).

J Crohns Colitis. 2019 Jun 14. pii: jjz119. doi: 10.1093/ecco-jcc/jjz119. [Epub ahead of print]

PMID:
31219157
10.

Effects of Nilvadipine on Cerebral Blood Flow in Patients With Alzheimer Disease.

de Jong DLK, de Heus RAA, Rijpma A, Donders R, Olde Rikkert MGM, Günther M, Lawlor BA, van Osch MJP, Claassen JAHR.

Hypertension. 2019 Aug;74(2):413-420. doi: 10.1161/HYPERTENSIONAHA.119.12892. Epub 2019 Jun 17.

PMID:
31203725
11.

CRISPR/CAS9 mutagenesis of a single r-opsin gene blocks phototaxis in a marine larva.

Neal S, de Jong DM, Seaver EC.

Proc Biol Sci. 2019 Jun 12;286(1904):20182491. doi: 10.1098/rspb.2018.2491. Epub 2019 Jun 5.

12.

The Dutch Breast Implant Registry: Registration of Breast Implant-Associated Anaplastic Large Cell Lymphoma-A Proof of Concept.

Becherer BE, de Boer M, Spronk PER, Bruggink AH, de Boer JP, van Leeuwen FE, Mureau MAM, van der Hulst RRJW, de Jong D, Rakhorst HA.

Plast Reconstr Surg. 2019 May;143(5):1298-1306. doi: 10.1097/PRS.0000000000005501.

PMID:
31033810
13.

Pioneers of Breast Implant-Associated Anaplastic Large Cell Lymphoma: History from Case Report to Global Recognition.

Miranda RN, Medeiros LJ, Ferrufino-Schmidt MC, Keech JA Jr, Brody GS, de Jong D, Dogan A, Clemens MW.

Plast Reconstr Surg. 2019 Mar;143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):7S-14S. doi: 10.1097/PRS.0000000000005564.

PMID:
30817551
14.

Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease.

Sluiter RL, Van Marrewijk C, De Jong D, Scheffer H, Guchelaar HJ, Derijks L, Wong DR, Hooymans P, Vermeulen SH, Verbeek ALM, Franke B, Van der Wilt GJ, Kievit W, Coenen MJH.

J Crohns Colitis. 2019 Jul 25;13(7):838-845. doi: 10.1093/ecco-jcc/jjz009.

PMID:
30698675
15.

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.

Bromberg JEC, Issa S, Bakunina K, Minnema MC, Seute T, Durian M, Cull G, Schouten HC, Stevens WBC, Zijlstra JM, Baars JW, Nijland M, Mason KD, Beeker A, van den Bent MJ, Beijert M, Gonzales M, de Jong D, Doorduijn JK.

Lancet Oncol. 2019 Feb;20(2):216-228. doi: 10.1016/S1470-2045(18)30747-2. Epub 2019 Jan 7.

PMID:
30630772
16.

A practical cytological approach to the diagnosis of breast-implant associated anaplastic large cell lymphoma.

Barbé E, de Boer M, de Jong D.

Cytopathology. 2019 Jul;30(4):363-369. doi: 10.1111/cyt.12678. Epub 2019 Feb 14. Review.

PMID:
30628128
17.

Spectatoring Mediates the Association Between Penis Appearance Concerns and Sexual Dysfunction.

Wyatt RB, de Jong DC, Holden CJ.

J Sex Marital Ther. 2019;45(4):328-338. doi: 10.1080/0092623X.2018.1526838. Epub 2018 Dec 29.

PMID:
30595102
18.

Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study.

Samaan MA, Forsyth K, Segal JP, De Jong D, Vleugels JLA, Elkady S, Kabir M, Campbell S, Kok K, Armstrong DG, Penez L, Arenaza AP, Seward E, Vega R, Mehta S, Rahman F, McCartney S, Bloom S, Patel K, Pollok R, Westcott E, Darakhshan A, Williams A, Koumoutsos I, Ray S, Mawdsley J, Anderson S, Sanderson JD, Dekker E, D'Haens GR, Hart A, Irving PM.

J Crohns Colitis. 2019 May 27;13(6):735-743. doi: 10.1093/ecco-jcc/jjy225.

PMID:
30590513
19.

Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease: Consequences for follow-up: Celiac disease, lymphoma and GI carcinoma.

van Gils T, Nijeboer P, Overbeek LI, Hauptmann M, Castelijn DA, Bouma G, Mulder CJ, van Leeuwen FE, de Jong D.

United European Gastroenterol J. 2018 Dec;6(10):1485-1495. doi: 10.1177/2050640618800540. Epub 2018 Sep 12.

20.

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma.

Martín-Garcia D, Navarro A, Valdés-Mas R, Clot G, Gutiérrez-Abril J, Prieto M, Ribera-Cortada I, Woroniecka R, Rymkiewicz G, Bens S, de Leval L, Rosenwald A, Ferry JA, Hsi ED, Fu K, Delabie J, Weisenburger D, de Jong D, Climent F, O'Connor SJ, Swerdlow SH, Torrents D, Beltran S, Espinet B, González-Farré B, Veloza L, Costa D, Matutes E, Siebert R, Ott G, Quintanilla-Martinez L, Jaffe ES, López-Otín C, Salaverria I, Puente XS, Campo E, Beà S.

Blood. 2019 Feb 28;133(9):940-951. doi: 10.1182/blood-2018-07-862151. Epub 2018 Dec 11.

PMID:
30538135
21.

Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma.

Mendeville M, Roemer MGM, van den Hout MFCM, Los-de Vries GT, Bladergroen R, Stathi P, Hijmering NJ, Rosenwald A, Ylstra B, de Jong D.

Blood. 2019 Jan 24;133(4):377-380. doi: 10.1182/blood-2017-12-822171. Epub 2018 Dec 3. No abstract available.

22.

Magnetic field compatible circuit quantum electrodynamics with graphene Josephson junctions.

Kroll JG, Uilhoorn W, van der Enden KL, de Jong D, Watanabe K, Taniguchi T, Goswami S, Cassidy MC, Kouwenhoven LP.

Nat Commun. 2018 Nov 5;9(1):4615. doi: 10.1038/s41467-018-07124-x.

23.

Development of sensitive ddPCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant forms.

Bosman KJ, Wensing AM, Pijning AE, van Snippenberg WJ, van Ham PM, de Jong DM, Hoepelman AI, Nijhuis M.

J Int AIDS Soc. 2018 Sep;21(9):e25185. doi: 10.1002/jia2.25185.

24.

Differences in the morphology, physiology and gene expression of honey bee queens and workers reared in vitro versus in situ.

De Souza DA, Kaftanoglu O, De Jong D, Page RE Jr, Amdam GV, Wang Y.

Biol Open. 2018 Nov 22;7(11). pii: bio036616. doi: 10.1242/bio.036616.

25.

Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity.

de Jong DC, Löwenberg M, Koumoutsos I, Ray S, Mawdsley J, Anderson S, Sanderson JD, Gecse K, Ponsioen CY, D'Haens GR, Irving PM, Samaan MA.

Inflamm Bowel Dis. 2019 Apr 11;25(5):937-944. doi: 10.1093/ibd/izy325.

PMID:
30329045
26.

Correction: The landscape of epilepsy-related GATOR1 variants.

Baldassari S, Picard F, Verbeek NE, van Kempen M, Brilstra EH, Lesca G, Conti V, Guerrini R, Bisulli F, Licchetta L, Pippucci T, Tinuper P, Hirsch E, de Saint Martin A, Chelly J, Rudolf G, Chipaux M, Ferrand-Sorbets S, Dorfmüller G, Sisodiya S, Balestrini S, Schoeler N, Hernandez-Hernandez L, Krithika S, Oegema R, Hagebeuk E, Gunning B, Deckers C, Berghuis B, Wegner I, Niks EH, Jansen FE, Braun K, de Jong D, Rubboli G, Talvik I, Sander V, Uldall P, Jacquemont ML, Nava C, Leguern E, Julia S, Gambardella A, d'Orsi G, Crichiutti G, Faivre L, Darmency V, Benova B, Krsek P, Biraben A, Lebre AS, Jennesson M, Sattar S, Marchal C, NordliJr DR, Lindstrom K, Striano P, Lomax LB, Kiss C, Bartolomei F, Lepine AF, Schoonjans AS, Stouffs K, Jansen A, Panagiotakaki E, Ricard-Mousnier B, Thevenon J, de Bellescize J, Catenoix H, Dorn T, Zenker M, Müller-Schlüter K, Brandt C, Krey I, Polster T, Wolff M, Balci M, Rostasy K, Achaz G, Zacher P, Becher T, Cloppenborg T, Yuskaitis CJ, Weckhuysen S, Poduri A, Lemke JR, Møller RS, Baulac S.

Genet Med. 2019 Aug;21(8):1896. doi: 10.1038/s41436-018-0325-9.

PMID:
30262923
27.

MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.

Yuan Y, Niu F, Nolte IM, Koerts J, de Jong D, Rutgers B, Osinga J, Azkanaz M, Terpstra M, Bystrykh L, Diepstra A, Visser L, Dzikiewicz-Krawczyk A, Kok K, Kluiver J, van den Berg A.

Cell Physiol Biochem. 2018;49(1):144-159. doi: 10.1159/000492850. Epub 2018 Sep 5.

28.

The landscape of epilepsy-related GATOR1 variants.

Baldassari S, Picard F, Verbeek NE, van Kempen M, Brilstra EH, Lesca G, Conti V, Guerrini R, Bisulli F, Licchetta L, Pippucci T, Tinuper P, Hirsch E, de Saint Martin A, Chelly J, Rudolf G, Chipaux M, Ferrand-Sorbets S, Dorfmüller G, Sisodiya S, Balestrini S, Schoeler N, Hernandez-Hernandez L, Krithika S, Oegema R, Hagebeuk E, Gunning B, Deckers C, Berghuis B, Wegner I, Niks E, Jansen FE, Braun K, de Jong D, Rubboli G, Talvik I, Sander V, Uldall P, Jacquemont ML, Nava C, Leguern E, Julia S, Gambardella A, d'Orsi G, Crichiutti G, Faivre L, Darmency V, Benova B, Krsek P, Biraben A, Lebre AS, Jennesson M, Sattar S, Marchal C, Nordli DR Jr, Lindstrom K, Striano P, Lomax LB, Kiss C, Bartolomei F, Lepine AF, Schoonjans AS, Stouffs K, Jansen A, Panagiotakaki E, Ricard-Mousnier B, Thevenon J, de Bellescize J, Catenoix H, Dorn T, Zenker M, Müller-Schlüter K, Brandt C, Krey I, Polster T, Wolff M, Balci M, Rostasy K, Achaz G, Zacher P, Becher T, Cloppenborg T, Yuskaitis CJ, Weckhuysen S, Poduri A, Lemke JR, Møller RS, Baulac S.

Genet Med. 2019 Feb;21(2):398-408. doi: 10.1038/s41436-018-0060-2. Epub 2018 Aug 10. Erratum in: Genet Med. 2018 Aug 29;:. Genet Med. 2018 Sep 27;:.

29.

Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Natkunam Y, Gratzinger D, Chadburn A, Goodlad JR, Chan JKC, Said J, Jaffe ES, de Jong D.

Blood. 2018 Nov 1;132(18):1871-1878. doi: 10.1182/blood-2018-04-842559. Epub 2018 Aug 6. Review.

30.

Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma-Reply.

de Jong D, de Boer M, van Leeuwen FE.

JAMA Oncol. 2018 Oct 1;4(10):1435. doi: 10.1001/jamaoncol.2018.2624. No abstract available.

PMID:
30054614
31.

Living in the intertidal: desiccation and shading reduce seagrass growth, but high salinity or population of origin have no additional effect.

Suykerbuyk W, Govers LL, van Oven WG, Giesen K, Giesen WBJT, de Jong DJ, Bouma TJ, van Katwijk MM.

PeerJ. 2018 Jul 20;6:e5234. doi: 10.7717/peerj.5234. eCollection 2018.

32.

Macrotextured Breast Implants with Defined Steps to Minimize Bacterial Contamination around the Device: Experience in 42,000 Implants.

de Boer M, Hauptmann M, de Jong D, van Leeuwen FE, Rakhorst HA, van der Hulst RRWJ.

Plast Reconstr Surg. 2018 Oct;142(4):590e-591e. doi: 10.1097/PRS.0000000000004783. No abstract available.

PMID:
30036331
33.

Intracerebral lymphoproliferative disorder in an MS patient treated with fingolimod.

de Jong BA, van Kempen ZLE, Wattjes MP, Smit PM, Peferoen L, Berry D, Chamuleau MED, de Jong D.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 10;5(5):e483. doi: 10.1212/NXI.0000000000000483. eCollection 2018 Sep. No abstract available.

34.

Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation With CCR5 Δ32 Homozygous Stem Cells.

Verheyen J, Thielen A, Lübke N, Dirks M, Widera M, Dittmer U, Kordelas L, Däumer M, de Jong DCM, Wensing AMJ, Kaiser R, Nijhuis M, Esser S.

Clin Infect Dis. 2019 Feb 1;68(4):684-687. doi: 10.1093/cid/ciy565.

PMID:
30020413
35.

Bacterascites: A study of clinical features, microbiological findings, and clinical significance.

Oey RC, van Buuren HR, de Jong DM, Erler NS, de Man RA.

Liver Int. 2018 Dec;38(12):2199-2209. doi: 10.1111/liv.13929. Epub 2018 Aug 10.

36.

Involvement of MicroRNAs in the Aging-Related Decline of CD28 Expression by Human T Cells.

Teteloshvili N, Dekkema G, Boots AM, Heeringa P, Jellema P, de Jong D, Terpstra M, Brouwer E, Pawelec G, Kok K, van den Berg A, Kluiver J, Kroesen BJ.

Front Immunol. 2018 Jun 18;9:1400. doi: 10.3389/fimmu.2018.01400. eCollection 2018.

37.

Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study.

Smits LJT, van Esch AAJ, Derikx LAAP, Boshuizen R, de Jong DJ, Drenth JPH, Hoentjen F.

Inflamm Bowel Dis. 2019 Jan 1;25(1):172-179. doi: 10.1093/ibd/izy227.

PMID:
29947795
38.

Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death.

Martins I, Raza SQ, Voisin L, Dakhli H, Allouch A, Law F, Sabino D, De Jong D, Thoreau M, Mintet E, Dugué D, Piacentini M, Gougeon ML, Jaulin F, Bertrand P, Brenner C, Ojcius DM, Kroemer G, Modjtahedi N, Deutsch E, Perfettini JL.

Cell Death Dis. 2018 Jun 18;9(7):716. doi: 10.1038/s41419-018-0747-y.

39.

Dynamic Regulation of Cerebral Blood Flow in Patients With Alzheimer Disease.

de Heus RAA, de Jong DLK, Sanders ML, van Spijker GJ, Oudegeest-Sander MH, Hopman MT, Lawlor BA, Olde Rikkert MGM, Claassen JAHR.

Hypertension. 2018 Jul;72(1):139-150. doi: 10.1161/HYPERTENSIONAHA.118.10900. Epub 2018 May 29.

PMID:
29844143
40.

Interobserver variation in CD30 immunohistochemistry interpretation; consequences for patient selection for targeted treatment.

Koens L, van de Ven PM, Hijmering NJ, Kersten MJ, Diepstra A, Chamuleau M, de Jong D.

Histopathology. 2018 Sep;73(3):473-482. doi: 10.1111/his.13647. Epub 2018 Jun 26.

PMID:
29758590
41.

Investigation into the cellular origins of posterior regeneration in the annelid Capitella teleta.

de Jong DM, Seaver EC.

Regeneration (Oxf). 2017 Dec 6;5(1):61-77. doi: 10.1002/reg2.94. eCollection 2018 Mar.

42.

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.

Schrader AMR, Jansen PM, Willemze R, Vermeer MH, Cleton-Jansen AM, Somers SF, Veelken H, van Eijk R, Kraan W, Kersten MJ, van den Brand M, Stevens WBC, de Jong D, Abdul Hamid M, Tanis BC, Posthuma EFM, Nijland M, Diepstra A, Pals ST, Cleven AHG, Vermaat JSP.

Blood. 2018 May 3;131(18):2086-2089. doi: 10.1182/blood-2017-12-822817. Epub 2018 Mar 7. No abstract available.

PMID:
29514783
43.

Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells.

Dzikiewicz-Krawczyk A, Diepstra A, Rutgers B, Kortman G, de Jong D, Koerts J, Bulthuis M, van der Sluis T, Seitz A, Visser L, Kok K, Kluiver J, van den Berg A.

Am J Pathol. 2018 May;188(5):1289-1299. doi: 10.1016/j.ajpath.2018.01.018. Epub 2018 Feb 17.

PMID:
29458013
44.

Addition of simethicone improves small bowel capsule endoscopy visualisation quality.

Krijbolder MS, Grooteman KV, Bogers SK, de Jong DJ.

Neth J Med. 2018 Jan;76(1):27-31.

45.

Corrigendum to "Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile." Neoplasia 2009, Feb;11(2):167-176.

Gibcus JH, Tan LP, Harms G, Schakel RN, de Jong D, Blokzijl T, Möller P, Poppema S, Kroesen BJ, van den Berg A.

Neoplasia. 2018 Jan 28;20(2):226. doi: 10.1016/j.neo.2017.11.008. eCollection 2018 Feb.

46.

Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn's Disease.

Visschedijk MC, Spekhorst LM, Cheng SC, van Loo ES, Jansen BHD, Blokzijl T, Kil H, de Jong DJ, Pierik M, Maljaars JPWJ, van der Woude CJ, van Bodegraven AA, Oldenburg B, Löwenberg M, Nieuwenhuijs VB, Imhann F, van Sommeren S, Alberts R, Xavier RJ, Dijkstra G, Nico Faber K, Aldaz CM, Weersma RK, Festen EAM.

J Crohns Colitis. 2018 Apr 27;12(5):582-588. doi: 10.1093/ecco-jcc/jjy001.

PMID:
29361163
47.

Benign and malignant tumors in Rubinstein-Taybi syndrome.

Boot MV, van Belzen MJ, Overbeek LI, Hijmering N, Mendeville M, Waisfisz Q, Wesseling P, Hennekam RC, de Jong D.

Am J Med Genet A. 2018 Mar;176(3):597-608. doi: 10.1002/ajmg.a.38603. Epub 2018 Jan 23.

48.

Distorted Beliefs about Luck and Skill and Their Relation to Gambling Problems and Gambling Behavior in Dutch Gamblers.

Cowie ME, Stewart SH, Salmon J, Collins P, Al-Hamdani M, Boffo M, Salemink E, de Jong D, Smits R, Wiers RW.

Front Psychol. 2017 Dec 22;8:2245. doi: 10.3389/fpsyg.2017.02245. eCollection 2017.

49.

Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast.

de Boer M, van Leeuwen FE, Hauptmann M, Overbeek LIH, de Boer JP, Hijmering NJ, Sernee A, Klazen CAH, Lobbes MBI, van der Hulst RRWJ, Rakhorst HA, de Jong D.

JAMA Oncol. 2018 Mar 1;4(3):335-341. doi: 10.1001/jamaoncol.2017.4510.

50.

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease.

Spekhorst LM, Oldenburg B, van Bodegraven AA, de Jong DJ, Imhann F, van der Meulen-de Jong AE, Pierik MJ, van der Woude JC, Dijkstra G, D'Haens G, Löwenberg M, Weersma RK, Festen EAM; Parelsnoer Institute and the Dutch Initiative on Crohn and Colitis.

World J Gastroenterol. 2017 Dec 14;23(46):8182-8192. doi: 10.3748/wjg.v23.i46.8182.

Supplemental Content

Loading ...
Support Center